AFP and Candidemia: Propensity score matched cohort analysis: 210 HSCT recipients receiving VCZ–AFP, 95 HSCT recipients receiving ISA–AFP;The incidence of proven/probable IFDs at day 180 was 2.9% (6/210) and 3.2% (3/95) in VCZ cohort and ISA cohort, respectively (p = 0.88);Not available;In the VCZ cohort 5/6 IFDs occurred after AFP discontinuation (4 probable IA,1 C. glabrata candidemia) and 1/6 was a very early probable IA;In the ISA cohort all cases were b-IFDs: three candidemia (two C. parapsilosis, one C. glabrata).